New Product Launch and Product Upgradation was the Key Growth Strategy in the Sterile Filtration Market

(IT-NEWSWIRE.COM, August 24, 2018 ) The global sterile filtration market is expected to USD 7.46 Billion by 2020 from USD 4.00 Billion in 2015, at a CAGR of 12.4%.

Sterile Filtration’s membrane filters, cartridges & capsules, syringe filters, bottle-top vacuum filters, filter funnels & holders and filtration accessories are mainly used for applications including bioprocesses, fill-finish process, utilities filtration, pre-filtration, and virus filtration.

Know More: https://www.marketsandmarkets.com/Market-Reports/sterile-filtration-market-256410424.html

The global sterile filtration market was dominated by Merck & Co., Inc. (U.S.), and Pall Corporation (U.S.) in 2014. These two companies together accounted for a share of ~32% of the global sterile filtration market in 2014. With its well established distribution network and broad product portfolio, Merck & Co., Inc. held the leadership position in the global sterile filtration market in 2014. Merck’s product portfolio includes a vast range of membrane filters and single-use systems, comprising Millipore Express PHF Hydrophilic Sterilizing-Grade Filters, single-pass tangential flow filtration (TFF) with Pellicon cassettes, etc. Over the past three years, the company adopted the strategy of new product launches and agreements to maintain its leadership position in the global sterile filtration market.

Pall Corporation (U.S.) held the second position in the sterile filtration market in 2014. The company has strong geographical presence and robust product portfolio for several sterile filtration applications such as cell culture growth media, buffer filtration, recombinant protein, virus filtration, and other bioprocesses applications. The company adopted merger & acquisition as its key business strategies to uphold its leading position in the global sterile filtration market. For instance, in December 2013, Pall Corporation acquired ATMI LifeSciences business for ~USD 185 million. ATMI LifeSciences is a technology leader in the field of single-use bioprocess systems and consumables for the pharmaceutical and biopharmaceutical industries.

The major players in this market include Merck & Co., Inc. (U.S.), General Electric Company (U.S.), Pall Corporation (U.S.), Parker Hannifin Corporation (U.S.), Sartorius Stedim Biotech Group (France), Sigma Aldrich Corporation (U.S.), 3M (U.S.), Porvair Filtration Group (U.K.), Starlabs Scientific (U.S.), and Sterlitech Corporation (U.S.).

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=256410424

The global sterile filtration market is highly evolved, with multiple product segments. An analysis of the market developments between 2013 and 2015 revealed that new product launches was the most important growth strategy employed by market leaders in this period. This strategy was adopted by all the players in this market.

The other important growth strategy adopted by players in this market is expansion, collaborations & partnerships. This strategy was adopted by the players market to enhance their product portfolio. These strategies were adopted by major the players in this market such as General Electric Company (U.S.), Parker Hannifin Corporation (U.S.), Sartorius Stedim Biotech Group (France), and Porvair Filtration Group (U.K.) between 2013 and 2015.

MarketsandMarkets

Mr. Shelly Singh

1-888-600-6441

sales@marketsandmarkets.com

Source: EmailWire.Com

Source: EmailWire.com

Technology News & Search Engine

New Product Launch and Product Upgradation was the Key Growth Strategy in the Sterile Filtration Market